Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM) cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results

被引:125
作者
Yukna, RA [1 ]
Callan, DP [1 ]
Krauser, JT [1 ]
Evans, GH [1 ]
Aichelmann-Reidy, ME [1 ]
Moore, K [1 ]
Cruz, R [1 ]
Scott, JB [1 ]
机构
[1] Louisiana State Univ, Sch Dent, Dept Periodont, New Orleans, LA 70119 USA
关键词
hydroxyapatite therapeutic use; bone; freeze-dried; demineralization; cell attachment protein; multi-center studies; bone matrix; comparison study; surgical flaps; periodontal diseases/therapy;
D O I
10.1902/jop.1998.69.6.655
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
A SYNTHETIC CELL-BINDING PEPTIDE (P-15) combined with anorganic bovine-derived hydroxyapatite bone matrix (ABM) was compared to demineralized freeze-dried bone allograft (DFDBA) and open flap debridement (DEBR) in human periodontal osseous defects in a controlled, monitored, multi-center trial. Following appropriate initial preparation procedures, flap surgery with defect and root debridement was performed. Three osseous defects per patient were treated randomly with one of three procedures after surgical preparation. Appropriate periodontal maintenance schedules were followed, and at 6 to 7 months re-entry flap surgery was performed for documentation and finalization of treatment. Analysis of variation (ANOVA) and t test analyses of patient mean values from 31 patients revealed that the combination ABM/P-15 grafts demonstrated significantly better mean defect fill of 2.8 +/- 1.2 mm (72.3%) versus a mean defect fill of 2.0 +/- 1.4 mm (51.4%) for defects treated with DFDBA (P < 0.05) and a mean defect fill of 1.5 +/- 1.3 mm (40.3%) (P < 0.05) for defects treated with DEER. Other hard tissue findings showed similar clinically superior results with the use of ABM/P-15. Relative defect fill results showed 87% positive (50% to 100% defect fill) responses with ABM/P-15, 58% positive responses with DFDBA, and 41% positive responses with DEBR, There were 8 to 9 times more failures (minimal response) with DFDBA and DEBR (26% to 29% frequency) than with ABM/P-15, Soft tissue findings showed no significant differences among treatments except for greater clinical attachment level gain with ABM/P-15 compared to DEER. These results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields better clinical results than either DFDBA or DEER. Further studies are needed to determine the relative roles of the ABM and/or the P-15 in these improved results.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 58 条
[1]   COMPARISON OF FREEZE-DRIED BONE ALLOGRAFT AND POROUS HYDROXYLAPATITE IN HUMAN PERIODONTAL DEFECTS [J].
BARNETT, JD ;
MELLONIG, JT ;
GRAY, JL ;
TOWLE, HJ .
JOURNAL OF PERIODONTOLOGY, 1989, 60 (05) :231-237
[2]   The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1(I) chain: Structural and biological evidence for conformational tautomerism on fiber surface [J].
Bhatnagar, RS ;
Qian, JJ ;
Gough, CA .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1997, 14 (05) :547-&
[3]  
Boetto J, 1984, J Can Dent Assoc, V50, P239
[4]   COMPARISON OF DECALCIFIED FREEZE-DRIED BONE ALLOGRAFT AND POROUS PARTICULATE HYDROXYAPATITE IN HUMAN PERIODONTAL OSSEOUS DEFECTS [J].
BOWEN, JA ;
MELLONIG, JT ;
GRAY, JL ;
TOWLE, HT .
JOURNAL OF PERIODONTOLOGY, 1989, 60 (12) :647-654
[5]   USE OF BOVINE-DERIVED HYDROXYAPATITE IN THE TREATMENT OF EDENTULOUS RIDGE DEFECTS - A HUMAN CLINICAL AND HISTOLOGIC CASE-REPORT [J].
CALLAN, DP ;
ROHRER, MD .
JOURNAL OF PERIODONTOLOGY, 1993, 64 (06) :575-582
[6]   HISTOLOGIC-STUDY OF HEALING OF HUMAN PERIODONTAL DEFECTS AFTER PLACEMENT OF POROUS HYDROXYLAPATITE IMPLANTS [J].
CARRANZA, FA ;
KENNEY, EB ;
LEKOVIC, V ;
TALAMANTE, E ;
VALENCIA, J ;
DIMITRIJEVIC, B .
JOURNAL OF PERIODONTOLOGY, 1987, 58 (10) :682-688
[7]   HISTOLOGIC-STUDY OF TISSUE-RESPONSE TO IMPLANTED HYDROXYLAPATITE IN 2 PATIENTS [J].
CHAO, SY ;
POON, CK .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1987, 45 (04) :359-362
[8]  
CHEUNG SS, 1993, STP PHARMA SCI, V3, P51
[9]  
Evans GH, 1997, CURR OPIN PERIODONT, V4, P75
[10]  
Fetner A E, 1994, Compendium, V15, P935